Literature DB >> 28611534

Therapeutic Strategies in Triple-Negative Breast Cancer.

Angelo Paradiso1, Christian F Singer2.   

Abstract

Entities:  

Year:  2017        PMID： 28611534      PMCID： PMC5465798          DOI： 10.1159/000460238

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  7 in total

Review 1.  Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification.

Authors:  Fouzia Guestini; Keely May McNamara; Takanori Ishida; Hironobu Sasano
Journal:  Expert Opin Ther Targets       Date:  2015-12-19       Impact factor: 6.902

Review 2.  Germline Mutations in Triple-Negative Breast Cancer.

Authors:  Eric Hahnen; Jan Hauke; Christoph Engel; Guido Neidhardt; Kerstin Rhiem; Rita K Schmutzler
Journal:  Breast Care (Basel)       Date:  2017-02-24       Impact factor: 2.860

Review 3.  Therapeutic Advances and New Directions for Triple-Negative Breast Cancer.

Authors:  Eleni Andreopoulou; Catherine M Kelly; Hayley M McDaid
Journal:  Breast Care (Basel)       Date:  2017-02-07       Impact factor: 2.860

Review 4.  Biological Subtypes of Triple-Negative Breast Cancer.

Authors:  Michael Hubalek; Theresa Czech; Hannes Müller
Journal:  Breast Care (Basel)       Date:  2017-02-20       Impact factor: 2.860

Review 5.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.

Authors:  Giampaolo Bianchini; Justin M Balko; Ingrid A Mayer; Melinda E Sanders; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2016-05-17       Impact factor: 66.675

Review 6.  Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease.

Authors:  Murugan Kalimutho; Kate Parsons; Deepak Mittal; J Alejandro López; Sriganesh Srihari; Kum Kum Khanna
Journal:  Trends Pharmacol Sci       Date:  2015-11-01       Impact factor: 14.819

7.  Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers.

Authors:  Pawel Domagala; Jolanta Hybiak; Janusz Rys; Tomasz Byrski; Cezary Cybulski; Jan Lubinski
Journal:  Oncotarget       Date:  2016-10-18
  7 in total
  2 in total

1.  Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3.

Authors:  Amer Ali Abd El-Hafeez; Hazim O Khalifa; Elham A M Mahdy; Vikas Sharma; Toru Hosoi; Pradipta Ghosh; Koichiro Ozawa; Monica M Montano; Takashi Fujimura; Ahmed R N Ibrahim; Mohamed A A Abdelhamid; Seung Pil Pack; Samia A Shouman; Seiji Kawamoto
Journal:  Pharmacol Rep       Date:  2019-01-07       Impact factor: 3.024

2.  Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway.

Authors:  Tiffany J Rios-Fuller; Gabriela Ortiz-Soto; Mercedes Lacourt-Ventura; Gerónimo Maldonado-Martinez; Luis A Cubano; Robert J Schneider; Michelle M Martinez-Montemayor
Journal:  Oncotarget       Date:  2018-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.